JPWO2020239065A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020239065A5 JPWO2020239065A5 JP2021570912A JP2021570912A JPWO2020239065A5 JP WO2020239065 A5 JPWO2020239065 A5 JP WO2020239065A5 JP 2021570912 A JP2021570912 A JP 2021570912A JP 2021570912 A JP2021570912 A JP 2021570912A JP WO2020239065 A5 JPWO2020239065 A5 JP WO2020239065A5
- Authority
- JP
- Japan
- Prior art keywords
- active ingredient
- carrier material
- group
- solvent
- solid dispersion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910468254 | 2019-05-31 | ||
| CN201910468254.9 | 2019-05-31 | ||
| PCT/CN2020/093206 WO2020239065A1 (zh) | 2019-05-31 | 2020-05-29 | 一种固体分散体及其制备方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022534610A JP2022534610A (ja) | 2022-08-02 |
| JPWO2020239065A5 true JPWO2020239065A5 (zh) | 2023-06-05 |
Family
ID=73553512
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021570912A Pending JP2022534610A (ja) | 2019-05-31 | 2020-05-29 | 固体分散体およびその調製方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220233449A1 (zh) |
| EP (1) | EP3977997A4 (zh) |
| JP (1) | JP2022534610A (zh) |
| KR (1) | KR20220016116A (zh) |
| CN (1) | CN113825511A (zh) |
| AU (1) | AU2020282470A1 (zh) |
| BR (1) | BR112021023691A2 (zh) |
| CA (1) | CA3141921A1 (zh) |
| MX (1) | MX2021014402A (zh) |
| TW (1) | TW202100527A (zh) |
| WO (1) | WO2020239065A1 (zh) |
| ZA (1) | ZA202110055B (zh) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023182332A1 (ja) * | 2022-03-22 | 2023-09-28 | 株式会社ダイセル | 口腔内崩壊錠用の添加剤組成物 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100087444A1 (en) * | 2007-03-12 | 2010-04-08 | Dr. Reddy's Laboratories Ltd. | Imatinib mesylate |
| PE20151335A1 (es) * | 2013-01-22 | 2015-09-18 | Hoffmann La Roche | Composicion farmaceutica con biodisponibilidad mejorada |
| CA2953798C (en) | 2014-07-07 | 2019-06-11 | Eternity Bioscience Inc. | Aminopyridazinone compounds as protein kinase inhibitors |
| WO2016082705A1 (zh) * | 2014-11-27 | 2016-06-02 | 华东理工大学 | 一种难溶性活性成分微粒、微粒制剂及其制备方法 |
| WO2016088074A1 (en) * | 2014-12-03 | 2016-06-09 | Dr. Reddy’S Laboratories Limited | Process for the preparation of amorphous ibrutinib |
| CN106924262A (zh) * | 2015-12-31 | 2017-07-07 | 常州方楠医药技术有限公司 | 一种无定型托法替尼枸橼酸盐与药用辅料的固体分散体及其制备方法 |
| CN107406453B (zh) * | 2016-01-05 | 2018-12-28 | 江苏恒瑞医药股份有限公司 | 一种btk激酶抑制剂的结晶形式及其制备方法 |
| IN201621020494A (zh) * | 2016-06-15 | 2017-12-22 | ||
| KR20200024237A (ko) * | 2017-07-04 | 2020-03-06 | 지앙수 헨그루이 메디슨 컴퍼니 리미티드 | 약학 조성물 및 이를 제조하기 위한 방법 |
-
2020
- 2020-05-29 JP JP2021570912A patent/JP2022534610A/ja active Pending
- 2020-05-29 EP EP20812881.9A patent/EP3977997A4/en active Pending
- 2020-05-29 AU AU2020282470A patent/AU2020282470A1/en active Pending
- 2020-05-29 KR KR1020217041733A patent/KR20220016116A/ko unknown
- 2020-05-29 TW TW109118103A patent/TW202100527A/zh unknown
- 2020-05-29 US US17/615,152 patent/US20220233449A1/en active Pending
- 2020-05-29 BR BR112021023691A patent/BR112021023691A2/pt unknown
- 2020-05-29 CA CA3141921A patent/CA3141921A1/en active Pending
- 2020-05-29 MX MX2021014402A patent/MX2021014402A/es unknown
- 2020-05-29 CN CN202080036373.8A patent/CN113825511A/zh active Pending
- 2020-05-29 WO PCT/CN2020/093206 patent/WO2020239065A1/zh unknown
-
2021
- 2021-12-06 ZA ZA2021/10055A patent/ZA202110055B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5794650B2 (ja) | 難溶性薬物の溶解性改善製剤 | |
| JP5289338B2 (ja) | 医薬固形製剤及びその製造方法 | |
| TW201729812A (zh) | 一種含有ｊａｋ激酶抑制劑或其可藥用鹽的醫藥組成物 | |
| WO2008020820A2 (en) | Pharmaceutical compositions comprising aripiprazole | |
| WO2015124995A1 (en) | Solid dosage forms of rivaroxaban | |
| JP6426293B2 (ja) | 安定性が改善された錠剤形態のデュタステリド組成物 | |
| WO2015141662A1 (ja) | 固体分散体 | |
| WO2020070144A1 (en) | Crystalline forms and processes of lenvatinib besylate | |
| EA027641B1 (ru) | Продукт сомикронизации, включающий ацетат улипристала | |
| JP2017518985A (ja) | アリサルタン・イソプロキシル固体分散体及び医薬組成物 | |
| EP2291079A2 (en) | Formulations for cathepsin k inhibitors | |
| JP6231613B2 (ja) | 有機液体希釈剤および粘度の非常に低いセルロースエーテルを含む組成物 | |
| JPWO2020239065A5 (zh) | ||
| CN109963565B (zh) | 一种药物组合物及其制备方法 | |
| RU2021133938A (ru) | Твердая дисперсия и способ ее получения | |
| KR101282847B1 (ko) | 실로스타졸을 함유하는 고체분산체 및 이를 포함하는 약학 조성물 | |
| CN105636580B (zh) | 包含1-[6-(吗啉-4-基)嘧啶-4-基]-4-(1h-1,2,3-三唑-1-基)-1h-吡唑-5-醇钠的药物剂型 | |
| RU2801812C2 (ru) | Кристаллические формы и способы получения ленватиниба безилата | |
| JP6199922B2 (ja) | 化学的な安定性が向上したイルベサルタン含有錠剤 | |
| WO2012114352A2 (en) | Pharmaceutical compositions of maraviroc and process for the preparation thereof | |
| JP2019073445A (ja) | アプレピタントを有効成分とする医薬組成物 | |
| WO2005034954A2 (en) | Pharmaceutical compositions of paroxetine containing microcrystalline cellulose, prepared by wet granulation | |
| JP2004505920A5 (zh) | ||
| JP2018009032A (ja) | 化学的な安定性が向上したイルベサルタン含有錠剤 | |
| JP2017200958A (ja) | 化学的な安定性が向上したイルベサルタン含有錠剤 |